Calibrate launched in 2020 as one of the first dedicated DTC weight loss platforms built around GLP-1 medications. The program combines GLP-1 prescribing with structured behavioral coaching, biometric tracking, and group accountability — a meaningfully different model from Hims, Ro, or generic telehealth platforms that prescribe GLP-1s without the wraparound coaching. After a 2023 restructuring that included significant layoffs and a pivot toward employer-sponsored plans, Calibrate continues to operate with a refined offering for individual subscribers. This calibrate review covers 2026 pricing, what the year-long program actually includes, GLP-1 medication access, the published outcomes data, and how Calibrate compares to Found, Noom Med, Ro, and Hims for medical weight loss.
How Calibrate’s program works
Calibrate is structured as a 12-month commitment to behavior change and medical weight loss, not a month-to-month medication subscription. The program includes an initial clinician evaluation for GLP-1 eligibility (or alternative medications), monthly clinician visits, weekly coaching sessions with a designated coach, a metabolic health curriculum delivered through the app, and biometric tracking via a Bluetooth scale and other tools.
The clinical model emphasizes the medication as one tool within a broader lifestyle intervention rather than a standalone treatment. Coaches are credentialed in behavior change and nutrition, and the curriculum is built around four core domains: food, sleep, exercise, and emotional health. For broader weight loss telehealth context, see our best telehealth for weight loss guide and our telehealth guide.
Calibrate pricing in 2026
The Calibrate Total Care program is $1,649 for the full 12-month commitment, billed upfront or in monthly installments. Medication is separate — patients with insurance coverage for GLP-1 medications pay their plan copay; patients without coverage pay either through compounded options where available (typically $200-450 per month) or through branded medications at full price ($1,000+ per month for Wegovy or Zepbound without insurance).
Calibrate offers a Results Guarantee — a partial refund if patients don’t lose at least 10% of their starting weight by the end of the 12-month program, subject to specific engagement requirements. Insurance integration: Calibrate doesn’t bill insurance for the program fee, but the platform helps patients navigate insurance coverage for the underlying GLP-1 prescription, which is where most of the medication cost lives. Some employer plans now include Calibrate as a benefit at reduced or zero cost to the employee.
What Calibrate includes that Hims and Ro don’t
The wraparound coaching is the primary differentiator. Calibrate coaches meet with patients weekly in 30-45 minute sessions covering goal-setting, troubleshooting, and behavior change. Compared to Hims or Ro weight loss programs, which provide essentially medication management with minimal lifestyle support, Calibrate’s coaching infrastructure is genuinely meaningful for patients who need accountability beyond the medication itself.
The published outcomes data is also distinctive. Calibrate has released periodic outcomes reports showing average weight loss in the 13-15% range at 12 months for program completers — comparable to the clinical trial data for the underlying GLP-1 medications. The honest framing is that program completers (those who engaged through 12 months) achieve outcomes consistent with strong clinical trial efficacy, while program dropouts achieve less.
What changed in 2023-2025
Calibrate restructured significantly in 2023 with layoffs and a leadership change. The program shifted from prescribing primarily branded medications to including compounded GLP-1 options where legally available. The 2024 FDA decisions on the semaglutide and tirzepatide shortage list reshaped which compounded options remained available, with most compounded semaglutide phased out in 2025.
As of 2026, Calibrate primarily prescribes branded Wegovy, Zepbound, and similar medications, with compounded options used selectively when clinically appropriate and legally available. The program structure (12-month commitment, weekly coaching, monthly clinician visits) has remained largely consistent through the restructuring. For comparison, see our Calibrate vs Found head-to-head.
Calibrate’s clinical eligibility and what to expect
Calibrate’s eligibility criteria align with FDA labeling for GLP-1 weight loss medications: BMI 27+ with at least one weight-related comorbidity (type 2 diabetes, hypertension, hyperlipidemia, sleep apnea, etc.) or BMI 30+ without comorbidities. The clinician evaluation reviews medical history, contraindications including personal or family history of medullary thyroid carcinoma per FDA guidance, and prior weight loss history.
Patients with contraindications including pregnancy, certain endocrine cancers, or pancreatitis history are appropriately screened out. The program is not a fit for patients seeking only behavioral coaching without medication, since the coaching is integrated with the medication-based clinical pathway. For coaching-only weight loss, see our Noom vs Calibrate comparison.
Where Calibrate falls short
The 12-month upfront commitment is a meaningful financial barrier. At $1,649 for the program plus medication costs, patients are committing to potentially $4,000-15,000 in total annual spending depending on medication choice and insurance coverage. The Results Guarantee mitigates the program-fee risk but doesn’t address medication cost.
Insurance integration is also limited. Calibrate doesn’t bill insurance for its program fee, and while the platform helps patients navigate medication coverage, the burden is largely on the patient to confirm what their plan covers. For patients with strong GLP-1 insurance coverage, the platform fee feels redundant relative to working with a primary care doctor and using insurance for the medication. For patients without coverage, the wraparound coaching has to genuinely move outcomes to justify the program fee on top of medication costs.
Calibrate vs Found, Noom, Ro, and Hims
Compared to Found, Calibrate has more structured coaching and a 12-month commitment model versus Found’s flexible monthly subscription. Both prescribe GLP-1s and other weight loss medications. See our Calibrate vs Found head-to-head for detailed comparison.
Compared to Noom Med, Calibrate’s coaching is more intensive while Noom Med leverages Noom’s broader behavioral curriculum. Compared to Ro and Hims weight loss programs, Calibrate offers significantly more coaching infrastructure but at a higher upfront commitment. For patients who don’t want the wraparound coaching, Ro or Hims may deliver the medication access at lower total cost. See our Ro vs Hims weight loss comparison and Found vs Noom piece for additional context.
Frequently Asked Questions
Does Calibrate take insurance?
Calibrate does not bill insurance for the program fee. The platform helps patients navigate insurance coverage for GLP-1 medications, which most major insurance plans cover for FDA-approved indications with proper documentation.
Is the 12-month commitment refundable?
The Results Guarantee provides a partial refund if patients meeting engagement requirements don’t lose at least 10% of their starting weight by month 12. Outside this guarantee, refunds are limited and subject to terms in the patient agreement.
Can I stay on Calibrate after the 12-month program?
Yes. Calibrate offers a maintenance program for patients completing the initial 12 months. The maintenance plan is monthly with continued clinician access and reduced coaching intensity.
Does Calibrate prescribe Ozempic or only Wegovy?
Calibrate primarily prescribes FDA-approved weight loss medications including Wegovy and Zepbound. Off-label Ozempic prescribing for weight loss is less common given Ozempic is FDA-approved for type 2 diabetes specifically.
What if I plateau on Calibrate?
The program includes plateau management as part of the standard clinician and coaching workflow. Strategies include dose adjustment, medication switching, and coaching focus on lifestyle factors. The 12-month structure is designed to handle plateaus rather than ending the relationship at the first stall.
The bottom line on Calibrate
Calibrate is the most structured medical weight loss platform in the DTC market, with the strongest coaching infrastructure and the most rigorous published outcomes data. The 12-month upfront commitment and program fee make it a significant financial decision, particularly for patients without strong GLP-1 insurance coverage. For patients who want coaching alongside medication and are willing to commit to a year-long program, Calibrate is a credible choice. For patients seeking just GLP-1 medication access without the coaching, Hims, Ro, or working with a primary care doctor are cheaper paths. The wraparound program is the value proposition; if you don’t need or use it, you’re paying for it anyway.